Steve Davis

Dallas’ Pegasus Park Expands with New Bridge Labs to Support Biotech Growth

According to an economic impact report by The Perryman Group, the 26-acre Pegasus Park campus, once fully built out under its master plan, is projected to generate $1.9 billion in annual gross product and create over 15,000 jobs.

Bridge Labs, the latest addition to the Pegasus Park campus, is designed to provide high-quality, flexible lab and office space for growth-stage biotech companies. "It's one-of-a-kind in the region," said Nicole Small, CEO of Lyda Hill Philanthropies.
MORE
CerSci
Dallas-based Biotech CerSci Acquired by ACADIA Pharmaceutical in $52.5M Deal
by | Aug 25, 2020
CerSci shareholders could net another $887 million in milestones and tiered royalties. The clinical-stage startup, which launched in 2015, is developing a new generation of non-opioid meds to treat acute and chronic pain.
MORE
Protecting your privacy. We have strengthened our Privacy Policy to better protect you. This Policy includes our use of cookies to give you the best online experience and provide functionality essential to our services. By clicking ‘I Accept’ or by continuing to use our website, you are consenting to our Privacy Policy.